Cutaneous melanoma in the era of molecular profiling-Reference-Cited by-同舟云学术

Cutaneous melanoma in the era of molecular profiling

Published:2009-08 Issue:9687 Volume:374 Page:362-365
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Thompson John F,Scolyer Richard A,Kefford Richard F

Publisher

Elsevier BV

Subject

General Medicine

Reference16 articles.

1. Leachman SA, Carucci J, Kohlmann W, et al. Guidelines for selection of familial melanoma patients for genetic assessment. J Am Acad Dermatol (in press).

2. Distinct sets of genetic alterations in melanoma;Curtin;N Engl J Med,2005

3. Oncogenic Braf induces melanocyte senescence and melanoma in mice;Dhomen;Cancer Cell,2009

4. Improving melanoma classification by integrating genetic and morphologic features;Viros;PLoS Med,2008

5. Phase I study of PLX4032: proof of concept for V600E BRAF mutation as a therapeutic target in human cancer;Flaherty;J Clin Oncol,2009

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Endoscopic ultrasound features of rectal melanoma: A case report and review of literature;World Journal of Clinical Cases;2024-06-06

2. Plasmid co-expressing siRNA-PD-1 and Endostatin carried by attenuated Salmonella enhanced the anti-melanoma effect via inhibiting the expression of PD-1 and VEGF on tumor-bearing mice;International Immunopharmacology;2024-01

3. Patients with melanoma treated with immune checkpoint inhibitors who had non-thyroid endocrine and skin immune-related adverse events have better prognosis: A systematic review and meta-analysis;Frontiers in Oncology;2022-09-14

4. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study;Journal for ImmunoTherapy of Cancer;2022-08

5. FLG Is a Potential Biomarker of Prognosis and Immunotherapy in Skin Cutaneous Melanoma;Applied Bionics and Biomechanics;2022-05-14